Ultrasound Evaluation of Superior Mesenteric Artery Measurements in a Healthy Pediatric Population

NCT ID: NCT04515251

Last Updated: 2025-07-31

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

289 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-04-27

Study Completion Date

2026-12-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Multicenter, prospective, observational research project on children aged from 10 to 15 years old undergoing abdominal ultrasound examinations during routine clinical practice.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Demographics data, clinical indications, ultrasound diagnosis, and ultrasound measurements will be recorded and stored on an database. Ultrasound measurements will be analyzed to define the normal range of values of Superior Mesenteric Artery (SMA) angle and Superior Mesenteric Artery - Aorta (SMA-A) distance in the pediatric population according to age, Body Mass Index (BMI), and fat parameters.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Superior Mesenteric Artery Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Ultrasound measurements

ultrasound measurement at the level of the left renal vein on a sagittal plane according to age

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Male and female children
* Age ranging from10 to 15 years, included
* Abdominal ultrasound examination to be performed for indications other than gastrointestinal evaluation
* Signed Informed Consent

Exclusion Criteria

* Presence of a disease that could distort the anatomy around the SMA (e.g., abdominal mass, lymphadenopathy, severe scoliosis, free abdominal fluid)
* Oncologic patients at risk of neoplastic cachexia.
Minimum Eligible Age

10 Years

Maximum Eligible Age

15 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Imaging Institute of Southern Switzerland

UNKNOWN

Sponsor Role collaborator

Ente Ospedaliero Cantonale, Bellinzona

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Marirosa Cristallo Lacalamita

MD Principal investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Marirosa Cristallo Lacalamita, MD

Role: PRINCIPAL_INVESTIGATOR

Imaging Institute of Southern Switzerland

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Imaging Institute of Southern Switzerland

Bellinzona, , Switzerland

Site Status RECRUITING

Hôpitaux Universitaires Genève

Geneva, , Switzerland

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Switzerland

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Marirosa Cristallo Lacalamita, MD

Role: CONTACT

+41 (0)91 811 84 75

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Marirosa Cristallo Lacalamita, MD

Role: primary

+41 (0)91 811 84 75

Sylviane Hanquinet, Prof

Role: primary

+41 (0)22 372 70 36

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

RAD-SMA-001

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Metabotyping of Overweight and Obese Children
NCT04632511 ACTIVE_NOT_RECRUITING NA
MAGNET Ingestion in Children
NCT05375981 COMPLETED